Position in OGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$65,757,401
+$44,962,645 QoQ
Shares Held
4,856,529
+39.9% QoQ
Ownership
1.85%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#7
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Mar 31, 2024CallValue
$1,355,480
CallShares
72,100
PutValue
$4,230,000
PutShares
225,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. OGN ranks #15 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,865,931 | $4,636,914,000 | |
| 2 | ABBV |
AbbVie Inc.
|
12,845,120 | $3,232,345,993 | |
| 3 | JNJ |
Johnson & Johnson
|
11,036,891 | $2,803,039,201 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,744,783 | $1,766,204,613 | |
| 5 | AMGN |
Amgen Inc
|
3,308,695 | $1,198,144,628 | |
| 6 | AZN |
Astrazeneca PLC
|
5,297,462 | $1,004,504,738 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,503,294 | $568,946,162 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,876,439 | $511,460,413 |
All Filings in OGN
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,757,401 | 4,856,529 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $20,794,756 | 3,471,579 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $30,795,163 | 4,295,002 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $29,557,004 | 2,767,510 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $57,690,784 | 5,959,792 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,419,741 | 1,774,328 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $49,124,889 | 3,292,553 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,963,797 | 416,299 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,653,343 | 418,036 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,230,000 | 225,000 | Put | Defined | 2024-05-13 | |
| 2024-03-31 | $1,355,480 | 72,100 | Call | Defined | 2024-05-13 | |
| 2024-03-31 | $11,852,477 | 630,451 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,834,831 | 543,331 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $3,244,500 | 225,000 | Put | Defined | 2024-02-09 | |
| 2023-09-30 | $11,421,351 | 657,912 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $7,271,886 | 349,442 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,462,823 | 359,814 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $19,378,307 | 693,817 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $13,871,378 | 592,794 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $15,043,353 | 445,729 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $14,461 | 414 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $14,992,792 | 429,224 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,522 | 50 | Call | Defined | 2022-02-14 | |
| 2021-12-31 | $185,136 | 6,080 | Put | Defined | 2022-02-14 | |
| 2021-12-31 | $15,492,835 | 508,796 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $76,466 | 2,332 | Put | Defined | 2021-11-15 | |
| 2021-09-30 | $48,857 | 1,490 | Call | Defined | 2021-11-15 | |
| 2021-09-30 | $16,201,832 | 494,109 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $24,298,234 | 802,982 | Shares | Defined | 2021-08-13 | |
| 2021-06-30 | $63,334 | 2,093 | Put | Defined | 2021-08-13 | |
| 2021-06-30 | $54,195 | 1,791 | Call | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||